Collegium Pharmaceutical Inc (COLL) returns
Collegium Pharmaceutical returns over 10 years
$1,000 invested in Collegium Pharmaceutical ten years ago was worth $1,563 at the close on October 30, 2026, with dividends reinvested: an average return of 4.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +9.1% | — | $1,091 | -0.9% |
| 3 months | -33.9% | — | $661.48 | +2.1% |
| Year to date | -48.6% | — | $514.04 | +11.7% |
| 1 year | -33.2% | — | $667.60 | +12.4% |
| 3 years | +9.6% | +3.1% | $1,096 | +88.5% |
| 5 years | +21.2% | +3.9% | $1,212 | +76.0% |
| 10 years | +56.3% | +4.6% | $1,563 | +316.6% |
Collegium Pharmaceutical return by calendar year
| Year | COLL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -48.6% | +11.7% | -60.3% |
| 2025 | +61.6% | +17.7% | +43.9% |
| 2024 | -6.9% | +24.9% | -31.8% |
| 2023 | +32.7% | +26.2% | +6.5% |
| 2022 | +24.2% | -18.2% | +42.4% |
| 2021 | -6.7% | +28.7% | -35.5% |
| 2020 | -2.7% | +18.4% | -21.0% |
| 2019 | +19.9% | +31.2% | -11.4% |
| 2018 | -7.0% | -4.6% | -2.4% |
| 2017 | +18.6% | +21.7% | -3.1% |
| 2016 | -43.4% | +12.0% | -55.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: COLL financials · COLL valuation
No forecast, no recommendation. This page describes Collegium Pharmaceutical Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.